HB FULLER (FUL)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FUL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FUL | Independent Director | 51 | ["Former Company Group Chairman, Cardiovascular & Specialty Solutions Group at Johnson & Johnson from 2022 to 2025","Member of Johnson & Johnson Medical Devices Group Operating committee","Led a diverse portfolio of medical device businesses","Held several roles at Ethicon overseeing the surgical instrument portfolio from 2018 to 2021","Three decades of experience leading major businesses in the medical technology industry","Worked closely with the medical community, research and development, manufacturing, and commercial functions","Knowledge and experience in global marketing, strategy, product development, P&L, and leading large global organizations"] | ["Audit Committee","Compensation Committee","Audit","Compensation","Corporate Governance and Nominating Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Former Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group at Johnson & Johnson, a global leader in the research and development, manufacture, and sale of a broad range of medical technologies, from 2022 to 2025. As a member of the Johnson & Johnson Medical Devices Group Operating committee, she led a diverse portfolio of medical device businesses including Electrophysiology, Neurovascular Intervention, Ear Nose and Throat and Breast Aesthetics. Previously, Ms. Martin held several roles of increasing responsibilities including Company Group Chairman, overseeing the surgical instrument portfolio of Ethicon, maker of Dermabond topical adhesives, from 2018 to 2021. Ms. Martin brings to the Board three decades of experience leading major businesses in the medical technology industry. As a business leader, she has worked closely with the medical community, research and development, manufacturing, and commercial functions to deliver innovation to patients around the world. At Johnson & Johnson she played a vital role in advancing the ambition of Johnson & Johnson MedTech. She also brings her knowledge and experience in global marketing, strategy, product development, P&L, and the ability to lead large global organizations.